Sichun Yang, PhD, a member of Case CCC's Molecular Oncology Program, and Alberto Montero, MD, a Developmental Therapeutics Program member, are looking for patient advocates for a follow-up study to ...
Dr. Melvin Silverstein answers the question: 'What's Invasive Ductal Carcinoma?' — -- Question: What is invasive ductal carcinoma? Answer: Invasive ductal carcinoma is the most common type of ...
Medpage Today on MSN
Year in Review: Breast Cancer
The findings came from analyses of two national cancer registries. ILC accounts for about 10% of all newly diagnosed breast ...
Women with estrogen receptor (ER)–positive, human epidermal growth factor receptor 2 (HER2)–negative invasive lobular carcinoma who are treated with endocrine therapy do not derive any additional ...
Rates of one type of breast cancer — invasive lobular carcinoma — have been rising in the United States more than three times faster than those of all other breast cancers combined over the past ...
Breast cancer is the most common cancer in the UK but what are the symptoms to look out for, what causes it and how can it be ...
Hosted on MSN
Deadly rare cancer surges in young people as experts sound alarm due to 'sheer numbers'
Scientists are warning that rates of a rare but highly deadly cancer are on the rise in the US, with cases climbing three times faster than other, more common, cancers. A key finding from 2012 to 2021 ...
WEDNESDAY, Oct. 8, 2025 (HealthDay news) — A rare but dangerous form of breast cancer is on the rise in the United States, a new report says. Lobular breast cancer rates are rising three times as fast ...
COLUMBUS, OHIO – New research at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) is using artificial ...
A fast-rising form of breast cancer that's harder to detect on mammograms now makes up more than one in ten cases in the United States, according to a new report from the American Cancer Society (ACS) ...
University of Colorado Cancer Center member Matthew Sikora, PhD, is a national leader in research into an understudied subtype of breast cancer that’s on the rise in American women, is often more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback